The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 21, 2023
Filed:
Dec. 28, 2020
Applicant:
Seagen Inc., Bothell, WA (US);
Inventors:
Shyra Gardai, Bothell, WA (US);
Phoenix Ho, Bothell, WA (US);
Assignee:
SEAGEN INC., Bothell, WA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); A61K 31/706 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01); A61K 38/07 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2875 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/706 (2013.01); A61K 38/07 (2013.01); A61K 39/3955 (2013.01); A61K 47/6803 (2017.08); A61K 47/6849 (2017.08); A61P 35/00 (2018.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/41 (2013.01); C07K 2317/732 (2013.01); C07K 2317/92 (2013.01);
Abstract
The invention provides methods of treating cancer, such as myeloid malignancies including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), with nonfucosylated anti-CD70 antibodies.